NextCure • NXTC
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Michael S. Richman$42.7M
Market Cap • 23/04/20242015
(há 9 anos)
2019
(5 years ago)
NASDAQ
Listagem
Beltsville
Sede • Maryland99
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
NXTCSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.